Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
143 participants
OBSERVATIONAL
2022-07-04
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Inclusion Criteria:
* Patients between the ages of 18- 70
* Drugs that have a systemically healthy and controlled treatment situation
* Drivers who have implant-supported fixed prostheses that have been at least six months after functional prosthetic loading Among these groups, it was checked whether periodontitis was seen in patients with peri-implantitis, gingivitis in patients with peri-implant mucositis, and whether healthy gums were seen in individuals with peri-implant health.
To determine the health and disease status of individuals' implants, plaque index (Silness Loe 1964), gingival index (Loe Silness 1963), bleeding on probing (Ainoma Bay 1975), pocket depth measurements, and clinical attachment level were collected.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Emergence Angle on Peri-implant Status
NCT07295743
The Influence of Mucosal Tissue Thickness on Soft and Hard Tissue Changes Around Implants
NCT02580721
Clinical and Biochemical Evaluation of the Efficacy of Non-Surgical Treatment Approaches in the Treatment of Peri-implantitis
NCT05201443
Periapical Lesions and Immediate Implants
NCT06521203
COMPARISION OF DIFFERENT TREATMENT METHODS OF PERI-IMPLANTITIS
NCT03241953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peri-implantitis
disease
compare to diseases
Peri-implant mucositis
disease
compare to diseases
Peri-implant health
disease
compare to diseases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
disease
compare to diseases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Drugs that have a systemically healthy and controlled treatment situation
* Drivers who have implant-supported fixed prostheses that have been at least six months after functional prosthetic loading
Exclusion Criteria
* Uncontrolled medical conditions
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tuğba ŞAHİN
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bolu Abant İzzet Baysal University
Bolu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022/163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.